Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Does using ethnic specific criteria improve the usefulness of the term metabolic syndrome? controversies and suggestions

International Journal of Obesity volume 31, pages 1340–1349 (2007)Cite this article

Abstract

The metabolic syndrome (MetS) is an important tool that identifies populations at increased risk for cardiovascular disease (CVD) and type 2 diabetes, targeting them for preventive measures. The criteria for the identification of the MetS were initially constructed from data in Caucasian populations. Recent research suggests that the current criteria for the MetS may not accurately characterize disease risk in non-Caucasian populations, either over or underestimating the risk in certain ethnic groups. Altering the criteria for each population by making ethnic-specific cutoffs as has been done with waist circumference will help in more accurate characterization. Using different combinations of the MetS criteria for different ethnic groups based CVD risk and factor analysis needs consideration. With better characterizations of patient populations, the ultimate goal would be to make MetS more accurate for predicting CVD risk while retaining the ease of screening afforded by the MetS. The proposed alterations of definition and criteria of the MetS would ensure its continued viability and sustainability.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Reaven GM . Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.

    Article  CAS  PubMed  Google Scholar 

  2. Kahn R, Buse J, Ferrannini E, Stern M . The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289–2304.

    Article  PubMed  Google Scholar 

  3. Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF . Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia 2005; 48: 649–656.

    Article  CAS  PubMed  Google Scholar 

  4. Tan CE, Ma S, Wai D, Chew SK, Tai ES . Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to asians? Diabetes Care 2004; 27: 1182–1186.

    Article  PubMed  Google Scholar 

  5. Takeuchi H, Saitoh S, Takagi S, Ohnishi H, Ohhata J, Isobe T et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men – the Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203–208.

    Article  PubMed  Google Scholar 

  6. Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 2005; 28: 1463–1471.

    Article  PubMed  Google Scholar 

  7. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.

    Article  PubMed  Google Scholar 

  8. Reaven G . The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin N Am 2004; 33: 283–303.

    Article  Google Scholar 

  9. Hanley AJ, Karter AJ, Festa A, D'Agostino Jr R, Wagenknecht LE, Savage P et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes 2002; 51: 2642–2647.

    Article  CAS  PubMed  Google Scholar 

  10. Snehalatha C, Sivasankari S, Satyavani K, Vijay V, Ramachandran A . Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India. Diabet Med 2000; 17: 152–157.

    Article  CAS  PubMed  Google Scholar 

  11. Meigs JB, D'Agostino Sr RB, Wilson PW, Cupples LA, Nathan DM, Singer DE . Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997; 46: 1594–1600.

    Article  CAS  PubMed  Google Scholar 

  12. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003; 108: 420–425.

    Article  CAS  PubMed  Google Scholar 

  13. Yusuf S, Reddy S, Ounpuu S, Anand S . Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746–2753.

    Article  CAS  PubMed  Google Scholar 

  14. Reddy KS, Yusuf S . Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596–601.

    Article  CAS  PubMed  Google Scholar 

  15. Ford ES, Giles WH, Dietz WH . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.

    Article  PubMed  Google Scholar 

  16. Ford ES . Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 2745–2749.

    Article  PubMed  Google Scholar 

  17. Florez H, Silva E, Fernandez V, Ryder E, Sulbaran T, Campos G et al. Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela. Diabetes Res Clin Pract 2005; 69: 63–77.

    Article  PubMed  Google Scholar 

  18. Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH . The prevalence of the metabolic syndrome among arab americans. Diabetes Care 2004; 27: 234–238.

    Article  PubMed  Google Scholar 

  19. Lee WY, Park JS, Noh SY, Rhee EJ, Kim SW, Zimmet PZ . Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 2004; 65: 143–149.

    Article  PubMed  Google Scholar 

  20. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716.

    Article  PubMed  Google Scholar 

  21. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689.

    Article  CAS  PubMed  Google Scholar 

  22. Meigs JB, Wilson PW, Nathan DM, D'Agostino Sr RB, Williams K, Haffner SM . Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003; 52: 2160–2167.

    Article  CAS  PubMed  Google Scholar 

  23. Alexander CM, Landsman PB, Teutsch SM, Haffner SM . NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210–1214.

    Article  CAS  PubMed  Google Scholar 

  24. Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG . Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care 2000; 23: 1242–1248.

    Article  CAS  PubMed  Google Scholar 

  25. Wannamethee SG, Shaper AG, Lennon L, Morris RW . Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005; 165: 2644–2650.

    Article  PubMed  Google Scholar 

  26. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403.

    Article  CAS  PubMed  Google Scholar 

  27. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005; 142: 611–619.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–1350.

    Article  CAS  PubMed  Google Scholar 

  29. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. Circulation 2005; 112: 2735–2752.

    Article  PubMed  Google Scholar 

  30. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM . Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004; 27: 2676–2681.

    Article  PubMed  Google Scholar 

  31. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 2004; 27: 2689–2694.

    Article  PubMed  Google Scholar 

  32. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245–1250.

    Article  PubMed  Google Scholar 

  33. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414–419.

    Article  CAS  PubMed  Google Scholar 

  34. Girman CJ, Rhodes T, Mercuri M, Pyorala K, Kjekshus J, Pedersen TR et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004; 93: 136–141.

    Article  CAS  PubMed  Google Scholar 

  35. Yusuf S, Reddy S, Ounpuu S, Anand S . Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104: 2855–2864.

    Article  CAS  PubMed  Google Scholar 

  36. Reddy KS . Primordial prevention of coronary heart disease in India: challenges and opportunities. Prev Med 1999; 29: S119–S123.

    Article  CAS  PubMed  Google Scholar 

  37. Hughes K, Aw TC, Kuperan P, Choo M . Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Commun Health 1997; 51: 394–399.

    Article  CAS  Google Scholar 

  38. Enas EA, Yusuf S, Sharma S . Coronary artery disease in South Asians. Second meeting of the International Working Group. 16 March 1997, Anaheim, California. Indian Heart J 1998; 50: 105–113.

    CAS  PubMed  Google Scholar 

  39. Palaniappan L, Wang Y, Fortmann SP . Coronary heart disease mortality for six ethnic groups in California, 1990–2000. Ann Epidemiol 2004; 14: 499–506.

    Article  PubMed  Google Scholar 

  40. McKeigue PM . Metabolic consequences of obesity and body fat pattern: lessons from migrant studies. Ciba Found Symp 1996; 201: 54–64. ; discussion 64-67, 188-193..

    CAS  PubMed  Google Scholar 

  41. Wasir JS, Misra A . The metabolic syndrome in Asian Indians: the impact of nutritional and socio-economic transition in India. Metab Syndr Relat Disord 2004; 2: 14–23.

    Article  PubMed  Google Scholar 

  42. Liu J, Hong Y, D'Agostino Sr RB, Wu Z, Wang W, Sun J et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 2004; 291: 2591–2599.

    Article  CAS  PubMed  Google Scholar 

  43. D'Agostino Sr RB, Grundy S, Sullivan LM, Wilson P . Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286: 180–187.

    Article  PubMed  Google Scholar 

  44. Mitchell BD, Stern MP, Haffner SM, Hazuda HP, Patterson JK . Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study. Am J Epidemiol 1990; 131: 423–433.

    Article  CAS  PubMed  Google Scholar 

  45. Bhopal R, Fischbacher C, Vartiainen E, Unwin N, White M, Alberti G . Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. J Public Health (Oxf) 2005; 27: 93–100.

    Article  Google Scholar 

  46. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM . Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 2004; 145: 445–451.

    Article  PubMed  Google Scholar 

  47. Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP . The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin 2005; 21: 1157–1159.

    Article  PubMed  Google Scholar 

  48. Barzilay JI, Spiekerman CF, Wahl PW, Kuller LH, Cushman M, Furberg CD et al. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet 1999; 354: 622–625.

    Article  CAS  PubMed  Google Scholar 

  49. Shiwaku K, Nogi A, Kitajima K, Anuurad E, Enkhmaa B, Yamasaki M et al. Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J Occup Health 2005; 47: 126–135.

    Article  PubMed  Google Scholar 

  50. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB . The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003; 163: 427–436.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Krauss RM, Winston M, Fletcher BJ, Grundy SM . Obesity: impact on cardiovascular disease. Circulation 1998; 98: 1472–1476.

    Article  PubMed  Google Scholar 

  52. Lim SC, Tan BY, Chew SK, Tan CE . The relationship between insulin resistance and cardiovascular risk factors in overweight/obese non-diabetic Asian adults: the 1992 Singapore National Health Survey. Int J Obes Relat Metab Disord 2002; 26: 1511–1516.

    Article  PubMed  Google Scholar 

  53. Rewers M, Zaccaro D, D'Agostino R, Haffner S, Saad MF, Selby JV et al. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27: 781–787.

    Article  CAS  PubMed  Google Scholar 

  54. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH . Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731–733.

    Article  CAS  PubMed  Google Scholar 

  55. Vikram NK, Pandey RM, Misra A, Sharma R, Devi JR, Khanna N . Non-obese (body mass index <25 kg/m2) Asian Indians with normal waist circumference have high cardiovascular risk. Nutrition 2003; 19: 503–509.

    Article  PubMed  Google Scholar 

  56. Enkhmaa B, Shiwaku K, Anuurad E, Nogi A, Kitajima K, Yamasaki M et al. Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for Japanese and Mongolians. Clin Chim Acta 2005; 352: 105–113.

    Article  CAS  PubMed  Google Scholar 

  57. Shiwaku K, Anuurad E, Enkhmaa B, Kitajima K, Yamane Y . Appropriate BMI for Asian populations. Lancet 2004; 363: 1077.

    Article  PubMed  Google Scholar 

  58. Razak F, Anand S, Vuksan V, Davis B, Jacobs R, Teo KK et al. Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (London) 2005; 29: 656–667.

    Article  CAS  Google Scholar 

  59. Unwin N, Harland J, White M, Bhopal R, Winocour P, Stephenson P et al. Body mass index, waist circumference, waist–hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK. J Epidemiol Commun Health 1997; 51: 160–166.

    Article  CAS  Google Scholar 

  60. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkanen L, Selby J et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996; 45: 742–748.

    Article  CAS  PubMed  Google Scholar 

  61. Misra A, Vikram NK . Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition 2004; 20: 482–491.

    Article  CAS  PubMed  Google Scholar 

  62. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW . Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999; 341: 1097–1105.

    Article  CAS  PubMed  Google Scholar 

  63. Stevens J, Juhaeri, Cai J, Jones DW . The effect of decision rules on the choice of a body mass index cutoff for obesity: examples from African American and white women. Am J Clin Nutr 2002; 75: 986–992.

    Article  CAS  PubMed  Google Scholar 

  64. Misra A . We need ethnic-specific criteria for classification of BMI. In: Medeiros-Neto G, Halpern, A, Bouchrad C(eds). Progress in Obesity Research, Proceedings of the 9th International Congress on Obesity, Sao Paulo, Brazil. John Libbey Eurotext Ltd. London, 2003, pp 547–553.

    Google Scholar 

  65. Misra A . Revision of limits of body mass index to define overweight and obesity are needed for the Asian ethnic groups. Int J Obes Relat Metab Disord 2003; 27: 1294–1296.

    Article  CAS  PubMed  Google Scholar 

  66. Misra A, Wasir JS, Vikram NK . Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. Nutrition 2005; 21: 969–976.

    Article  PubMed  Google Scholar 

  67. Misra A, Vikram NK, Gupta R, Pandey RM, Wasir JS, Gupta VP . Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes (London) 2006; 30: 106–111.

    Article  CAS  Google Scholar 

  68. Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension 2002; 40: 679–686.

  69. Zhang XF, Attia J, D'Este K, Yu XH, Wu XG . Prevalence and magnitude of classical risk factors for coronary heart disease in a cohort of 4400 Chinese steelworkers over 13.5 years follow-up. Eur J Cardiovasc Prev Rehabil 2004; 11: 113–120.

    Article  PubMed  Google Scholar 

  70. Araneta MR, Barrett-Connor E . Subclinical coronary atherosclerosis in asymptomatic Filipino and white women. Circulation 2004; 110: 2817–2823.

    Article  PubMed  Google Scholar 

  71. Cappuccio FP . Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin. J Hum Hypertens 1997; 11: 571–576.

    Article  CAS  PubMed  Google Scholar 

  72. Khattar RS, Swales JD, Senior R, Lahiri A . Racial variation in cardiovascular morbidity and mortality in essential hypertension. Heart 2000; 83: 267–271.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005; 96: 399–404.

    Article  CAS  PubMed  Google Scholar 

  74. Haffner SM, D'Agostino Jr R, Goff D, Howard B, Festa A, Saad MF et al. LDL size in African Americans, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 1999; 19: 2234–2240.

    Article  CAS  PubMed  Google Scholar 

  75. Rewers M, Shetterly SM, Hoag S, Baxter J, Marshall J, Hamman RF . Is the risk of coronary heart disease lower in Hispanics than in non-Hispanic whites? The San Luis Valley Diabetes Study. Ethn Dis 1993; 3: 44–54.

    CAS  PubMed  Google Scholar 

  76. Rewers M, Shetterly SM, Baxter J, Marshall JA, Hamman RF . Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol 1992; 135: 1321–1330.

    Article  CAS  PubMed  Google Scholar 

  77. Ma S, Cutter J, Tan CE, Chew SK, Tai ES . Associations of diabetes mellitus and ethnicity with mortality in a multiethnic Asian population: data from the 1992 Singapore National Health Survey. Am J Epidemiol 2003; 158: 543–552.

    Article  PubMed  Google Scholar 

  78. Tai ES, Lim SC, Chew SK, Tan BY, Tan CE . Homeostasis model assessment in a population with mixed ethnicity: the 1992 Singapore National Health Survey. Diabetes Res Clin Pract 2000; 49: 159–168.

    Article  CAS  PubMed  Google Scholar 

  79. UK Prospective Diabetes Study Group. Ethnicity and cardiovascular diseases.The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes (UK Prospective Diabetes Study 32). Diabetes Care 1998; 21: 1271–1277.

  80. Baskar V, Kamalakannan D, Holland MR, Singh BM . Does ethnic origin have an independent impact on hypertension and diabetic complications? Diabetes Obes Metab 2006; 8: 214–219.

    Article  CAS  PubMed  Google Scholar 

  81. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM . The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003; 26: 3153–3159.

    Article  PubMed  Google Scholar 

  82. Lawlor DA, Ebrahim S, May M, Davey Smith G . Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol 2004; 159: 1013–1018.

    Article  PubMed  Google Scholar 

  83. Cossrow N, Falkner B . Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab 2004; 89: 2590–2594.

    Article  CAS  PubMed  Google Scholar 

  84. Hodge AM, Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J et al. Leptin and other components of the metabolic syndrome in Mauritius – a factor analysis. Int J Obes Relat Metab Disord 2001; 25: 126–131.

    Article  CAS  PubMed  Google Scholar 

  85. The IDF consensus worldwide definition of the metabolic syndrome. Available at http://www.idf.org/home (accessed July 2006). 2005.

  86. Misra A, Wasir JS, Pandey RM . An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians. Diabetes Care 2005; 28: 398–403.

    Article  PubMed  Google Scholar 

  87. Hermanns-Le T, Scheen A, Pierard GE . Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol 2004; 5: 199–203.

    Article  PubMed  Google Scholar 

  88. Ridker PM . High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol 2003; 92: 17K–22K.

    Article  CAS  PubMed  Google Scholar 

  89. Lim S, Lee HK, Kimm KC, Park C, Shin C, Cho NH . C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population. CRP as risk factor of metabolic syndrome. Diabetes Res Clin Pract 2005; 70: 126–133.

    Article  CAS  PubMed  Google Scholar 

  90. Ridker PM, Wilson PW, Grundy SM . Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818–2825.

    Article  CAS  PubMed  Google Scholar 

  91. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino Jr RB, Haffner SM . Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 2005; 54: 3140–3147.

    Article  CAS  PubMed  Google Scholar 

  92. Francke S, Manraj M, Lacquemant C, Lecoeur C, Lepretre F, Passa P et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 2001; 10: 2751–2765.

    Article  CAS  PubMed  Google Scholar 

  93. Wang XL, Gu DF, Fan ZJ, Sun F, Yu QJ, Wu XG et al. The insertion/deletion polymorphism of angiotensin I converting enzyme gene and coronary heart disease – discordant sib pair analysis and transmission/disequilibrium test]. Yi Chuan 2002; 24: 117–120.

    PubMed  Google Scholar 

  94. Lee YJ, Tsai JC . ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002; 25: 1002–1008.

    Article  CAS  PubMed  Google Scholar 

  95. Guettier JM, Georgopoulos A, Tsai MY, Radha V, Shanthirani S, Deepa R et al. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. J Clin Endocrinol Metab 2005; 90: 1705–1711.

    Article  CAS  PubMed  Google Scholar 

  96. Miller M, Rhyne J, Ericson1 R, Misra A . The APOC3 Promoter Polymorphisms T-455C and C-482T are Associated with the Metabolic Syndrome in Two Diverse Populations. Annual Scientific Sessions of the American College of Cardiology, Orlando, FL, 7 March, 2005.

  97. Alberti KG, Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.

    Article  CAS  PubMed  Google Scholar 

  98. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–3421.

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Disease Division, Stanford University School of Medicine, Stanford, CA, USA

    D Banerjee

  2. Department of Internal Medicine, All India Institute of Medical Sciences, New Delhi, India

    A Misra

  3. Center for Diabetes, Obesity, and Cholesterol Disorders (C-DOC), Diabetes Foundation (India), SDA, New Delhi, India

    A Misra

Authors
  1. D Banerjee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Misra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Misra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Banerjee, D., Misra, A. Does using ethnic specific criteria improve the usefulness of the term metabolic syndrome? controversies and suggestions. Int J Obes 31, 1340–1349 (2007). https://doi.org/10.1038/sj.ijo.0803619

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803619

Keywords

This article is cited by

Search

Advanced search

Quick links